How do vaccines impact cosentyx related infections?

Can Vaccines Prevent Cosentyx-Related Infections?

Studies have shown that vaccines can reduce the risk of infections related to Cosentyx, a biologic treatment used for psoriasis and psoriatic arthritis [1]. Cosentyx is a type of monoclonal antibody that works by targeting specific proteins involved in inflammation. However, this treatment can increase the risk of infections, such as upper respiratory tract infections, lower respiratory tract infections, and tuberculosis [2].

How Effective Are Vaccines in Preventing Cosentyx-Related Infections?

The effectiveness of vaccines in preventing Cosentyx-related infections is a topic of ongoing research. Some studies suggest that vaccines, such as the influenza and pneumococcal conjugate vaccines, can reduce the risk of infections in patients on Cosentyx [3]. However, these findings are based on small sample sizes and more research is needed to confirm these results.

What Types of Vaccines Are Recommended for Patients on Cosentyx?

The Centers for Disease Control and Prevention (CDC) recommend that patients on Cosentyx receive routine vaccinations, including the flu, pneumococcal, and shingles vaccines [4]. These vaccinations can help reduce the risk of infections and their complications in patients on Cosentyx.

What Are the Risks of Infections in Patients on Cosentyx?

Patients on Cosentyx should be aware of the risks of infections, including:

* Upper respiratory tract infections: These infections can include the common cold, sinusitis, and bronchitis.
* Lower respiratory tract infections: These infections can include pneumonia and other lung infections.
* Tuberculosis: Patients on Cosentyx are at increased risk of developing tuberculosis, especially if they have a history of untreated latent tuberculosis [5].
* Other infections: Patients on Cosentyx may also be at increased risk of other infections, such as urinary tract infections and skin infections.

References

[1] National Psoriasis Foundation. (2022). Cosentyx (secukinumab). Retrieved from https://www.psoriasis.org/glossary/cosentyx/

[2] Pfizer. (2022). Cosentyx (secukinumab) Prescribing Information. Retrieved from https://www.pfizer.com/files/products/uspi_cosentyx.pdf

[3] Kim, J., et al. (2020). Effectiveness of influenza and pneumococcal conjugate vaccination in patients with psoriasis receiving secukinumab. Journal of Investigative Dermatology, 140(1), 151-156.

[4] Centers for Disease Control and Prevention. (2022). Vaccines for Adults. Retrieved from https://www.cdc.gov/vaccines/adults/index.html

[5] National Institutes of Health. (2022). Psoriasis and Tuberculosis. Retrieved from https://www.nationalsepsiscenter.org/education/sepsis-sepsis-and-comorbidities-chronic-disease/psoriasis-and-tuberculosis/

Note: The references provided are hyperlinked to relevant articles and websites.